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Background: Post-operative pancreatic fistula (POPF) is a common and potentially devastating com-
plication of pancreas resection. Management of this complication is important to the pancreas surgeon.
Objective: The aim of the present study was to evaluate whether drain data accurately predicts clinically
significant POPF.
Methods: A prospectively maintained database with daily drain amylase concentrations and output
volumes from 177 consecutive pancreatic resections was analysed. Drain data, demographic and opera-
tive data were correlated with POPF (ISGPF Grade: A – clinically silent, B – clinically evident, C – severe)
to determine predictive factors.
Results: Twenty-six (46.4%) out of 56 patients who underwent distal pancreatectomy and 52 (43.0%)
out of 121 patients who underwent a Whipple procedure developed a POPF (Grade A-C). POPFs were
classified as A (24, 42.9%) and C (2, 3.6%) after distal pancreatectomy whereas they were graded as
A (35, 28.9%), B (15, 12.4%) and C (2, 1.7%) after Whipple procedures. Drain data analysis was limited
to Whipple procedures because only two patients developed a clinically significant leak after distal
pancreatectomy.The daily total drain output did not differ between patients with a clinical leak (Grades
B/C) and patients without a clinical leak (no leak and Grade A) on post-operative day (POD) 1 to 7.
Although the median amylase concentration was significantly higher in patients with a clinical leak on
POD 1–6, there was no day that amylase concentration predicted a clinical leak better than simply
classifying all patients as ‘no leak’ (maximum accuracy = 86.1% on POD 1, expected accuracy by chance
= 85.6%, kappa = 10.2%).
Conclusion: Drain amylase data in the early post-operative period are not a sensitive or specific
predictor of which patients will develop clinically significant POPF after pancreas resection.
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Introduction
Much of the morbidity associated with pancreatic resection
can be attributed to the development of post-operative pancre-
atic fistula (POPF).1 The incidence of POPF varies depending on
the definition applied but is considered to be between 10%
and 30%.2–9 POPF is associated with delayed gastric emptying,
intra-abdominal abscess, wound infection, sepsis, haemorrhage,
need for reoperation, extended hospitalization and mortality.8,10–12
These complications also increase the costs associated with
pancreas surgery.
As a result of the high incidence of POPF, surgical dogma has
been to routinely place a drain near the pancreatic anastomosis
after pancreatic resection. However, recent data from a random-
ized prospective trial have challenged this view suggesting that
drains are not only unnecessary after pancreatic resection but
increase the rate of infection.13 Some surgeons have abandoned
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the use of drains whereas others have begun to remove drains
early in the post-operative period based on drain volume and
amylase content. However, little is known about the dynamic
post-operative changes in drain volume and amylase concentra-
tion and how these factors correlate with clinically significant
POPF. For example, it is unknown whether drain volume,
amylase concentration or both are important in predicting clini-
cally significant POPF and whether these factors are more pre-
dictive on any particular post-operative day. Controversy over the
use of drains and the significant impact of POPF on outcomes
for patients undergoing pancreas resection has made prediction
and severity stratification of POPF an important topic of
investigation.3,14–21
Currently, there are no established guidelines for interpretation
of drain volumes and amylase concentration that suggest an
evolving clinically significant POPF. Such data would be useful in
deciding when to remove drains and which patients require closer
monitoring. We hypothesized that higher drain amylase concen-
trations and volumes would correlate with clinically significant
POPF. Data from all patients undergoing pancreatic resection
were recorded in a prospectively maintained database. Daily drain
volume and amylase concentrations from 177 patients were
correlated with outcomes including POPF severity using the
ISGPF definition.
Methods
The analysis was based on data from review of a prospectively
maintained database and patient medical records. The prospective
electronic web-based database tracked data on patient demo-
graphics, clinical history, past medical history, family and social
history, physical findings, diagnostic tests, therapeutic inter-
ventions including detailed operative data, complications, patho-
logical data and survival for all patients. Highly-specific and
standardized definitions were used for all variables. After obtain-
ing informed consent, data were entered into the database in
real time by a trained data analyst under the supervision of
the surgeon. All data were backed up by source documents and
accuracy of data entered into the electronic database was perio-
dically reviewed. Permission for this study was obtained from an
Institutional Review Board.
Patients with pancreas pathology requiring resection from 23
August 2004 to 16 April 2009 were included in the study. One
hundred and seventy-seven patients treated with either aWhipple
procedure (pancreaticoduodenectomy) or distal pancreatectomy
by a single surgeon (W.E.F.) were included. Patients who under-
went enucleation of a tumour or a central pancreatectomy were
excluded. Demographic data analysed included age at diagnosis,
gender, race and ethnicity. Past medical history and diagnosis were
included. Operative data analysed included pancreatic texture as
judged by the surgeon (hard vs. soft), pancreatic duct size which
was measured at surgery (dilated vs. normal), estimated blood loss
(EBL), operative time (both recorded from the anaesthesia record
not the surgeon’s note) and anastomotic technique. POPF was
defined and graded using ISGPF criteria.22
Until recently, there has been no consensus definition and
severity grading system for POPFs making comparison of POPF
rates for various operative techniques and post-operative manage-
ment strategies difficult. The International Study Group on
Pancreatic Fistula (ISGPF) proposed a three-tiered definition of
POPF (Table 1).22 This classification scheme is based on clinical
signs, radiographic imaging, the need for re-intervention and the
development of sepsis. In the present study, the ISGPF criteria
were strictly applied and presence of a single criterion advanced
the grading to the next highest category. For example, a patient
with a chemical POPF who had no clinical evidence other than
one isolated temperature of >101.5 F was considered a Grade B
POPF. Total daily drain output (sum of all drains) and maximum
drain amylase concentration (highest concentration in any drain)
were recorded and used for the analysis.
Table 1 Summary of the ISGPF definition of POPF used in our analysis
Criteria None Grade A Grade B Grade C
Chemical POPFa No Yes Yes Yes
Clinical Condition Well Well Often Well III appearing
Specific Treatment No No Yes/No Yes
US/CT (if obtained) Negative Negative Negative/Positive Positive
>14 day LOS No No Yes Yes
Signs of infection No No Yes Yes
Readmission No No Yes/No Yes/No
Sepsis No No No Yes
Reoperation No No No Yes
Death related to POPF No No No Possibly
Presence of any criteria in the column categorized a fistula within that grade.
aChemical POPF defined as drain amylase  360 U/L on or any time after POD 3.
POPF, post-operative pancreatic fistula; LOS, length of stay.
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All other complications within 30 days of the operation were
also included in the analysis. We defined post-operative length of
stay (LOS) as days in the hospital beginning on post-operative day
1 and including the day of discharge (although patients generally
left in the morning). Gastroparesis was defined as presence of a
nasogastric tube and or failure to resume solid oral intake by
post-operative day 10. A wound infection was defined as a puru-
lent drainage from the wound associated with a positive wound
drainage culture. Intra-abdominal infection was defined as pres-
ence of a fluid collection requiring percutaneous drainage or
surgery with a positive culture. Fever was defined as a temperature
recording greater than or equal to 101.5°F. Biliary leak was defined
as drainage from the abdomen of fluid with a documented biliru-
bin level equal to or greater than serum values or of a green colour
that clearly indicated a clinical bile leak. Re-operation was defined
as a return to the operating room but excluded patients that
required a percutaneous drain. Return to the intensive care unit
(ICU) was defined as transfer of the patient back to the ICU ward
after initial discharge which was usually on the first post-operative
morning.
During this study period, drains were managed uniformly by an
established protocol. For the Whipple procedure, two drains were
introduced through the right flank. One was placed posterior and
one anterior to the biliary and pancreatic anastomoses. For the
distal pancreatectomy, one drain was introduced through the left
flank and positioned near the transected margin of the pancreas.
Drains were sutured in place at the skin level. Drains were left in
place until they drained less than or equal to 20 mL per day for
two consecutive days and the amylase concentration was less than
3¥ serum (<360 U/L).
ISGPF POPF classifications were determined for each patient
based on total drain output (sum of all drains) and maximum
drain amylase concentration (highest from an individual drain) to
ensure the threshold for detecting POPFs was as sensitive as pos-
sible. Patients were classified as having a POPF if the maximum
drain amylase concentration was greater than three times the
upper limit of the normal value in our laboratory (120 U/L ¥ 3 =
360 U/L) on or after post-operative day (POD) 3. Within the
cohort of patients classified as having a POPF, sub-stratification
into Class A, B and C POPF was based on ISGPF criteria using
additional clinical outcome data.
Demographic, past medical history and operative data were
analysed to determine predictors of Grade B and C POPF.
Demographic and patient-specific data collected included: age,
pre-operative serum albumin, body mass index, pre-operative
bilirubin and chronic medical conditions (coronary artery
disease, diabetes mellitus, chronic obstructive pulmonary disease
and chronic renal insufficiency). Procedural data included: pan-
creatic texture, pancreatic duct size, operative time and estimated
blood loss (EBL) from the anaesthesia record, anastomotic tech-
nique and the placement of a pancreatic duct stent.
Descriptive statistics were used to summarize demographics
and patient characteristics. Comparisons between patients who
developed a POPF and patients with no POPF were made using
Fisher’s exact test for categorical variables and Wilcoxon’s rank-
sum test for continuous variables. Exact logistic regression analy-
sis was performed to examine factors associated with development
of POPF for patients who underwent the Whipple procedure.
Data were log-transformed to reduce variations. The optimal
threshold was estimated by minimizing Euclidean distance away
from a perfect predictor on the upper left corner of the receiver-
operating characteristic (ROC) curve with 100% sensitivity and
100% specificity for total drain output, and amylase in drains on
post-operative days 1–7.
Results
The records of 181 patients were identified as undergoing pancre-
atic resection. Two central pancreatectomies and two enucleation
procedures were excluded. Of the remaining 177 patients, 121
underwent pancreaticoduodenectomy (Whipple procedure) and
56 underwent distal pancreatectomy.
Whipple procedure (pancreaticoduodenectomy)
Demographic and intra-operative data for patients undergoing a
Whipple procedure are presented in Table 2.Of these 121 patients,
52 (43.0%) were men, 109 (90.1%) were White and the median
age of the group was 64. The most common reasons for surgery
were pancreatic adenocarcinoma (46.3%), ampullary lesions
(17.4%), chronic pancreatitis (15.7%) and cystic lesions (14.0%).
Intra-operatively, the distribution of patients with hard (49.1%)
and soft (50.9%) pancreatic texture was similar. The number
of patients with a normal (3 mm, 46.3%) or dilated (>3 mm,
53.7%) pancreatic duct was also comparable. An end-to-side,
duct-to-mucosa anastomosis of the pancreas to the jejunum was
utilized far more commonly (95.0%) compared with intussus-
ception (‘dunking’) (5.0%). Median EBL was 400 mL with an
operating time of 442 min.
Post-operative data are presented in Table 3. Median length of
stay was 8 days. The most common post-operative complications
included abdominal wound infection (12.4%), gastroparesis
defined as failure to eat solid food by POD 10 (5.8%) and a fever
(temperature > 101.5 F) (5.0%). Reoperation was performed on
six patients (5.0%), two of whom required ICU admission. Five
other patients (4.1%) required ICU care without necessitating
further surgical intervention.
After surgery, 52 patients (43.0%) developed at least a chemical
POPF according to the ISGPF definition and 35 (28.9%) of
the POPFs were clinically silent (Grade A). Seventeen patients
(14.1%) developed a clinically significant POPF (Grade B or C).
Only two of these patients had complications of a severity suffi-
cient to meet the criteria for a Grade C POPF.
No chemical (Grade A) POPF was detected in 3 out of the 6
patients requiring reoperation. Wound infection was noted in 15
patients, of which 40% had a clinical POPF. Of the 7 patients with
gastroparesis, 3 (42.9%) had a clinical POPF. Both patients (1.7%)
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with a biliary leak also had a POPF. Two patients developed intra-
abdominal infections after surgery. However, neither of these
patients had elevated drain amylase concentrations and were
therefore not classified as having developed a POPF.
Distal pancreatectomy
Demographic data for patients who underwent a distal pancreate-
ctomy is presented in Table 2. Fifty-six procedures were per-
formed on patients with a median age of 62 years. Twenty-six
patients (46.4%) were men, 42 (85.7%) were White and the most
common diagnoses were cystic lesions (30.4%), adenocarcinoma
(28.6%) and chronic pancreatitis (17.9%). Almost half the
patients had a normal size pancreatic duct, although information
about the size of the duct was not available in 35.7%. Twenty-nine
patients (69.1%) had a soft pancreatic texture. Control of the
pancreatic resection margin was achieved by stapling (41.1%)
or suturing (58.9%). Median EBL was 300 mL with a median
operating time of 269 min.
As expected, LOS and complication rates were lower for
distal pancreatectomy as compared to theWhipple procedure. The
most common post-operative complication, as with the Whipple
procedure, was wound infection (7.1%). Other complications
included intra-abdominal infection (3.6%), gastroparesis (1.8%)
and fever (1.8%). Two patients (3.6%) required reoperation, one
of whom required ICU level care. Both these patients were classi-
fied as having Grade C POPFs.
Factors predictive of clinically significant POPF
Analysis of factors predictive of clinically significant POPFs was
only performed in the Whipple procedure cohort given the low
number of clinically significant POPFs in the distal pancreatec-
tomy group. No statistically significant association was detected
between demographic or operative characteristics and POPF.
There was no association between the development of a clinically
significant post-operative pancreatic leak and any of the follow-
ing characteristics: age, gender, body mass index (BMI), a past
medical history of coronary artery disease, diabetes, chronic
obstructive pulmonary disease, renal insufficiency, pre-operative
serum bilirubin or albumin levels, pathologic diagnoses/
Table 2 Demographic and intra-operative data
Whipple
procedure
(n = 121)
Distal
pancreatectomy
(n = 56)
Age, median
(interquartile range)
64 (56–72) 61.5 (46–68)
Men 52 (43.0%) 26 (46.4%)
Race
White 109 (90.1%) 48 (85.7%)
Black 10 (8.3%) 5 (8.9%)
Other 2 (1.7%) 3 (5.4%)
Ethnicity
Hispanic 17 (14.0%) 6 (10.7%)
Non-hispanic 104 (86.0%) 50 (89.3%)
Diagnosis
Adenocarcinoma 56 (46.3%) 16 (28.6%)
Neuroendocrine carcinoma 4 (3.3%) 7 (12.5%)
Chronic pancreatitis 19 (15.7%) 10 (17.9%)
Ampullary lesion 21 (17.4%) 0 (0.0%)
Cystic lesions 17 (14.0%) 17 (30.4%)
IPMN 14 (11.6%) 6 (10.7%)
MCN 2 (1.7%) 4 (7.1%)
Serous cystadenoma 1 (0.8%) 7 (12.5%)
Other 4 (3.3%) 6 (10.7%)
Duct size
Normal 56 (46.3%) 26 (72.2%)
Dilated 65 (53.7%) 10 (27.8%)
Pancreas texture
Hard 54 (49.1%) 13 (31.0%)
Soft 56 (50.9%) 29 (69.1%)
Anastomtic technique
End-to-side duct-to-mucosa 115 (95.0%) –
End-to-end intussuscepted 6 (5.0%) –
Stapled – 23 (41.1%)
Sutured – 33 (58.9%)
Operating time (min), Median
(interquartile range)
442 (375–529) 268.5 (214.5–325)
Estimated blood loss, median
(interquartile range)
400 (250–700) 300 (175–800)
IPMN, intraductal papillary mucinous neoplasm; MCN, mucinous cystic
neoplasm.
Table 3 Post-operative data
Whipple
procedure
(n = 121)
Distal
pancreatectomy
(n = 56)
Length of stay, median
(interquartile range)
8 (7–11) 7 (6–8)
POD last drain removed,
median (interquartile range)
16 (11–25) 15 (11–25)
POPF
None 69 (57.0%) 30 (53.6%)
A 35 (28.9%) 24 (42.9%)
B 15 (12.4%) 0 (0%)
C 2 (1.7%) 2 (3.6%)
Gastroparesis 7 (5.8%) 1 (1.8%)
Wound infection 15 (12.4%) 4 (7.1%)
Intra-abdominal infection 2 (1.7%) 2 (3.6%)
Fever > 101.5 6 (5.0%) 1 (1.8%)
Biliary leak 2 (1.7%) 0 (0%)
Reoperation 6 (5.0%) 2 (3.6%)
Return to ICU 5 (4.1%) 1 (1.8%)
POD, post-operative days; POPF, post-operative pancreatic fistula.
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indication for resection, the presence of a soft pancreas or small
duct, operative time or EBL or the use of a pancreatic duct stent
for the anastomosis.
Among the 17 patients (14%) who had a clinically significant
(Grade B/C) leak after the Whipple procedure and 2 patients
(4%) after a distal pancreatectomy, there was a wide range of
severity (Table 4). Three of the four patients with a Grade C leak
had to be returned to the operating room and were returned
to the ICU. One of these patients had a combined biliary and
pancreatic leak. The other biliary leak was very transient and
resolved within 24 h with percutaneous drainage. Most of the
fistulas were controlled with the operatively placed drains but
a few required either an additional percutaneous drain or
required percutaneous drainage because their operative drains
had already been removed.
As expected, patients with a clinically significant POPF were
more likely to have a complicated post-operative course. Patients
with a clinically significant POPF were more likely to develop a
wound infection (P = 0.0073), a fever > 101.5°F (P = 0.036) and
biliary leak (P = 0.019). Not surprisingly, rates of ICU admission
(P = 0.0196) and re-operation (P = 0.0357) were also higher in
patients with a clinically significant POPF (Table 4).
Daily drain volume data for the first 10 days after surgery is
presented in Table 5. There were no significant differences in the
volume of drain output between patients with no leak or chemical
leaks (Grade A) and patients with a clinically significant leak
(Grade B/C).
Daily drain amylase concentration data for the first 10 days
after surgery are presented in Table 6. ROC curves for drain
amylase concentration were analysed and optimal thresholds for
daily amylase concentration were calculated (Fig. 1). Although the
median amylase concentration was significantly higher in patients
with a clinical leak on POD 1–6, there was no day that amylase
concentration predicted a clinical leak better than simply classify-
ing all patients as ‘no leak’ (maximum accuracy = 86.1% on POD
1, expected accuracy by chance = 85.6%, kappa = 10.2%).
Discussion
There is no standard of care concerning themanagement of drains
after pancreatic resection and practice patterns vary among sur-
geons. Some surgeons do not measure the drain amylase concen-
tration at all. They follow the daily drain volume and check a drain
amylase concentration only if the nature of the fluid suggests a
POPF. Others check the drain amylase concentration just before
they remove the drain when the volume decreases to about 20 mL/
day. Recently, some surgeons have begun to abandon the use
of prophylactic drains after pancreatic resection whereas others,
fearing the impact of undrained fluid with a high amylase
concentration, have begun to remove drains earlier in the post-
operative period if the amylase concentration drops.
In 2004, we incorporated daily drain amylase measurements
on all patients after pancreatic resection as part of our clinical
pathway with an eventual retrospective study in mind. We now
have an enormous data set that allows us to examine the relation-
ship between drain volume, amylase concentration and clinical
outcome. We hoped that this would provide surgeons with evi-
dence to guide decisions about drain management. The purpose
of the present study was to determine if drain data (output
volume, amylase concentration, or both) can be used to predict
which patients will develop a clinically significant POPF. This
question is important because recent data suggest that the use of
drains after pancreatic resectionmay increase the rate of infection.
The dogma that all pancreatic anastomoses require drainage has
been challenged. Some surgeons are apprehensive about abandon-
ing the use of drains altogether because of the high incidence of
POPF. A compromise position taken by some is to use drains
selectively and remove the drain as early as possible.23 But when is
it safe to remove the drain? When the volume drops to a certain
level? When the amylase concentration is below a certain level?
Many surgeons assume that increased drainage with high amylase
content signals a developing clinically significant POPF, but is this
supported by any data?
Table 4 Complication rates for patients who underwent a Whipple procedure
None/A leaks
(n = 104)
B/C leaks
(n = 17)
Pa
Length of Stay, Median (interquartile range) 7 (7–10) 16 (7–19) 0.0062b
Gastroparesis 4 (3.9%) 3 (17.7%) 0.0569
Wound infection 9 (8.7%) 6 (35.3%) 0.0073
Intra-abdominal infection 2 (1.9%) 0 (0%) 1.0000
Fever > 101.5 3 (2.9%) 3 (17.7%) 0.0357
Biliary leak 0 (0%) 2 (11.8%) 0.0187
Any complication 16 (15.4%) 17 (100%) <0.0001
Reoperation 3 (2.9%) 3 (17.7%) 0.0357
Return to ICU 2 (1.9%) 3 (17.7%) 0.0196
aP-value was based on Fisher's exact test.
bP-value was based on Wilcoxon's rank-sum test.
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In the present study, there were no differences in the volume of
drain output among patients with no leak or a chemical leak
(Grade A) and a clinical leak (Grade B/C) but drain amylase
concentrations were significantly greater on post-operative days
1–6 in patients who went on to develop a clinically significant
POPF (Grade B/C). However, in terms of predictive value, drain
amylase output is inadequate as a predictor of the clinical severity
of POPF. In this study ROC analysis indicated that optimizing
sensitivity is associated with a substantial rise in rates of false
positive predictions making the drain data of marginal clinical
benefit. In our series, there is a high incidence of chemical leaks
(Grade A).
Other studies have examined the usefulness of specific concen-
trations of drain amylase in the post-operative period as a predic-
tor of POPF with varying results.23–33 For example, drain amylase
greater than 5000 IU/L on postoperative day 1 or >200 mL/day
output with amylase greater than 5 times serum amylase concen-
tration on postoperative day 5 have been proposed as clinically
useful predictors of POPF. An important difference between our
study and previous work is that we measured the drain amylase
every day until the drains were removed.Although this is not done
in clinical practice, we measured the drain amylase daily so the
true value of these measurements on any given day could be
accurately assessed. Our study captures every patient that could
possibly be categorized as having a chemical (Grade A) pancreatic
leak. Therefore, in our study, the smaller subset of patients with
high drain amylase concentrations who are destined to develop a
clinically significant leak (Grade B/C) cannot be distinguished
using drain amylase concentration data.
In the present study, we observed a 14% incidence of clinically
significant POPF which is very similar to other contemporary
studies using the ISGPF definition.10,29,30 However, our overall rate
of fistula (Grades A, B, and C) was 39% compared to 27 to 30% in
other studies. Among the patients we observed with a POPF, most
(67%) were chemical leaks (Grade A) whereas other studies have
reported about 47% of the POPFs as chemical leaks.
Table 5 Daily drain volume measurements for patients who underwent a Whipple Procedure and Distal Pancreatectomy
Drain volume and whipple procedure (mL)
POD No leak (n = 69) Leak
Chemical leak (n = 35) Clinical leak (n = 17)
N Mean  SD Median (range) N Mean  SD Median (range) N Mean  SD Median (range)
1 66 152.2  109.4 135 (0–615) 34 168.7  112.4 142.5 (20–490) 17 182.4  121.2 165 (25–460)
2 69 183.5  205.3 124 (0–1220) 33 151  130 110 (0–480) 16 190.2  170.8 112.5 (50–635)
3 68 301.1  366.8 202.5 (0–2330) 33 186  151.3 155 (10–590) 17 257  343.4 160 (7–1400)
4 64 314.0  274.3 240 (10–1415) 35 225.5  184.6 190 (5–630) 16 389.9  412.7 276.5 (34–1625)
5 65 332.1  463.0 210 (15–3510) 34 282.4  237 227.5 (0–960) 16 376.9  349.8 297.5 (10–1165)
6 64 307.8  373.6 220 (4–2675) 35 220.4  196.2 200 (3–802) 17 335.6  318.3 270 (13–1310)
7 54 380.6  535.9 217.5 (10–3000) 30 195.3  145.1 190 (2–538) 15 241.3  204.6 170 (20–700)
8 33 314.8  355.7 195 (0–1543) 17 146.9  131.4 95 (3–490) 10 274.8  317.9 142.5 (40–1055)
9 27 301.7  415.4 105 (0–1430) 10 187.5  191.7 169 (16–666) 10 242.9  173.6 210 (45–470)
10 24 257.1  379.2 100 (0–1366) 9 85.8  107.7 50 (0–306) 11 224.2  194.1 115 (31–610)
Drain volume and distal pancreatectomy (mL)
POD No leak (n = 30) Leak
Chemical leak (n = 24) Clinical leak (n = 2)
N Mean  SD Median (range) N Mean  SD Median (range) N Mean  SD Median (range)
1 30 155.8  104.6 122.5 (0–405) 24 139  120.4 100 (30–560) 2 227.5  137.9 227.5 (130–325)
2 30 116.8  111.5 90 (0–500) 24 101.3  113.3 70 (0–390) 2 107.5  38.9 107.5 (80–135)
3 30 109.8  120.5 72.5 (5–600) 24 76.9  92.9 62.5 (6–485) 2 130  113.1 130 (50–210)
4 30 139.4  197.3 50 (5–880) 23 82.5  65.2 60 (25–295) 2 195  183.8 195 (65–325)
5 30 151.1  241.7 85 (0–1080) 23 100.9  83.9 90 (10–315) 2 132.5  130.8 132.5 (40–225)
6 27 137.3  219.0 80 (3–1105) 16 111.9  96.1 82.5 (15–360) 2 149  171.1 149 (28–270)
7 15 95.7  124.7 45 (0–390) 13 78.5  46.9 75 (5–160) 1 50  – 50 (50–50)
8 7 98.9  80.0 90 (15–260) 10 205.3  344.8 105 (28–1175) 1 45  – 45 (45–45)
9 5 64.8  60.9 35 (24–170) 8 134.3  103.4 85 (20–285) 1 60  – 60 (60–60)
10 4 95.0  98.8 95 (0–190) 4 88.8  128 40 (0–275) 1 35  – 35 (35–35)
POD, post-operative days.
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Daily drain data from this study suggests that many patients,
perhaps a third or more, leak amylase-rich fluid from their pan-
creatic anastomosis in the early post-operative period but most
heal and have an uneventful recovery. Other patients that eventu-
ally developed a clinically significant leak did not have amylase-
rich fluid in the drains in the early post-operative period but
developed this later in their course. The pathophysiology involved
in a clinically significant POPF may involve later post-operative
events such as infection or coincide with resumption of oral intake
and stimulation of pancreatic secretion.31–33 This may explain why
drain data in the earlier post-operative period fails to predict
clinically significant POPF.
Although the main goal of the present study was to determine
the predictive value of drain data for POPF, we also examined
other factors that may predict a leak.
Other studies have reported that a soft pancreas and small
pancreatic duct diameter have been found to correlate with the
development of a clinically significantPOPF.9,24–25 The risk of POPF
may be further increased when there is excessive intra-operative
blood loss26 Additionally, diabetes, heart disease and prolonged
operative time have also been associated in some studies with
clinically significant POPFs.11,27We did not identify any statistically
significant associations between clinically significant POPF
and pancreatic texture, duct size, age, operative time, EBL, pre-
operative serum albumin, body mass index, pre-operative biliru-
bin, chronic medical conditions (coronary artery disease, diabetes
mellitus, chronic obstructive pulmonary disease and chronic renal
insufficiency) and the placement of a pancreatic duct stent.
The strengths of the present study include the large amount
of daily drain data allowing application of the ISGPF definition.
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Figure 1 Optimal thresholds for daily amylase concentration demonstrated sub-optimal specificity and sensitivity for all days assessed
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It must be emphasized that drain data were obtained every day in
an effort to clearly define the value of drain data after pancreatic
resection. In addition, the cases are extremely well annotated in a
prospective fashion with defined criteria for complications result-
ing in highly accurate data. Themain weakness of this study is that
a relatively small number of cases performed by a single surgeon
were analysed.A large prospective multicentre study with accurate
drain and clinical data is required to obtain sufficient cases to
definitively determine if drain volume and amylase concentration
can allow the surgeon to identify patients who will eventually
develop serious complications.
Conclusion
We think the take-home message for the clinician from our data
and previous studies is that many of the patients undergoing
pancreatic resection will have elevated drain amylase concentra-
tions and most of these patients will recover uneventfully. This
fact was reflected in the ISGPF definition that stratifies POPFs
based on clinical severity. Furthermore, our study demonstrates
that the degree to which the amylase is elevated and the volume of
drain output on any particular post-operative day is not necessar-
ily an accurate way to predict which patients will develop a clini-
cally significant POPF. Therefore, drain data may be useful to
define the presence of a chemical POPF but the severity can only
be determined by clinical outcomes. Patients at higher risk for a
POPF such as those with a soft pancreas may require more careful
clinical observation.
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